Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes. (Q53623548)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

author name string

Kazuki Yamanaka

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Palma Rocchi

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Hideaki Miyake

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Ladan Fazli

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Alan So

5

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Uwe Zangemeister-Wittke

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Martin E Gleave

7

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

publication date

1 June 2006

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

BJU International

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

97

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

1300-1308

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Hormonal therapy: historical perspective to future directions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Mechanisms of the development of androgen independence in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

BCL-2 family: regulators of cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Clusterin: physiologic and pathophysiologic considerations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Clusterin inhibits apoptosis by interacting with activated Bax

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Antisense oligonucleotide-based therapeutics for cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Antisense therapy for cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Enhanced gene silencing by the application of multiple specific small interfering RNAs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Antisense therapy: current status in prostate cancer and other malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Functional analysis of the human MCL-1 gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

The Bcl-2 family of proteins: regulators of cell death and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Glycobiology and cancer: meeting summary and future diections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense BCL-XL and antisense Bcl-2 oligonucleotides plus taxol after castration in the Shionogi tumor model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.06147.X

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53623548&oldid=1365425937"